EBV 201: Multicenter Expanded Access Protocol of Allogeneic Epstein-Barr Virus Cytotoxic T Lymphocytes (EBV-CTLs) for Patients with EBV-Associated Viremia or Malignancies for Whom there are No Appropriate Alternative Therapies

Project: Research project

Project Details

StatusActive
Effective start/end date8/1/17 → 8/31/50

Funding

  • Atara Biotherapeutics